Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-18

Clinical Trial Update: Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating radiofrequency ablation plus radiotherapy for small hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN